Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-15 | Vir Biotechnology, Inc. | O'Byrne Jason
(EVP & Chief Financial Officer) |
A | Common Stock | A | 75000 | $0.00 - $0.00 | $0 |
| 2024-11-06 | Vir Biotechnology, Inc. | de Verneuil Vanina
(EVP and General Counsel) |
S | Common Stock | D | 4397 | $10.11 - $10.11 | $44,453 |
| 2024-11-01 | Vir Biotechnology, Inc. | de Verneuil Vanina
(EVP and General Counsel) |
S | Common Stock | D | 3750 | $7.20 - $9.47 | $32,332 |
| 2024-10-23 | Vir Biotechnology, Inc. | SCANGOS GEORGE A
(Director) |
J | Common Stock | A | 2393080 | $0.00 - $0.00 | $0 |
| 2024-09-09 | Vir Biotechnology, Inc. | Napolitano Janet
(Director) |
S | Common Stock | D | 12190 | $7.80 - $7.80 | $95,032 |
| 2024-06-11 | Vir Biotechnology, Inc. | Ramasastry Saira
(Director) |
S | Common Stock | D | 4000 | $10.95 - $10.95 | $43,789 |
| 2024-05-30 | Vir Biotechnology, Inc. | Sigal Charles Ell...
(Director) |
A | Common Stock | A | 8000 | $0.00 - $0.00 | $0 |
| 2024-05-30 | Vir Biotechnology, Inc. | SCANGOS GEORGE A
(Director) |
A | Common Stock | A | 8000 | $0.00 - $0.00 | $0 |
| 2024-05-30 | Vir Biotechnology, Inc. | SATO VICKI L
(Director) |
A | Common Stock | A | 8000 | $0.00 - $0.00 | $0 |
| 2024-05-30 | Vir Biotechnology, Inc. | Ramasastry Saira
(Director) |
A | Common Stock | A | 8000 | $0.00 - $0.00 | $0 |
| 2024-05-30 | Vir Biotechnology, Inc. | NELSEN ROBERT
(Director) |
A | Common Stock | A | 8000 | $0.00 - $0.00 | $0 |
| 2024-05-30 | Vir Biotechnology, Inc. | Napolitano Janet
(Director) |
A | Common Stock | A | 8000 | $0.00 - $0.00 | $0 |
| 2024-05-30 | Vir Biotechnology, Inc. | MORE ROBERT J
(Director) |
A | Common Stock | A | 8000 | $0.00 - $0.00 | $0 |
| 2024-05-30 | Vir Biotechnology, Inc. | Hatfield Jeffrey S.
(Director) |
A | Common Stock | A | 8000 | $0.00 - $0.00 | $0 |
| 2024-05-29 | Vir Biotechnology, Inc. | Farid Ramy
(Director) |
A | Common Stock | A | 16000 | $0.00 - $0.00 | $0 |
| 2024-05-29 | Vir Biotechnology, Inc. | BISCHOFBERGER NOR...
(Director) |
A | Common Stock | A | 16000 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |